Sandoz shells out $275M in latest effort to move past 'legacy' price-fixing litigation

Sandoz has agreed to pay another group of plaintiffs in the long-running price-fixing litigation it inherited from former parent company Novartis, marking a further step by the company to leave the "legacy" allegations behind.